|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.18 USD | +2.08% |
|
-0.52% | +10.74% |
| Nov. 18 | UBS Initiates Coverage on Sabra Health Care REIT With Neutral Rating, $20 Price Target | MT |
| Nov. 06 | Sabra Health Care REIT, Inc., Q3 2025 Earnings Call, Nov 06, 2025 |
| Capitalization | 4.78B 4.07B 3.81B 3.58B 6.59B 433B 7.2B 44.42B 17.23B 204B 17.94B 17.57B 745B | P/E ratio 2025 * |
27.6x | P/E ratio 2026 * | 26.2x |
|---|---|---|---|---|---|
| Enterprise value | 7.35B 6.26B 5.85B 5.5B 10.13B 666B 11.07B 68.25B 26.47B 314B 27.57B 26.99B 1,145B | EV / Sales 2025 * |
9.72x | EV / Sales 2026 * | 8.73x |
| Free-Float |
98.83% | Yield 2025 * |
6.26% | Yield 2026 * | 6.4% |
Last Transcript: Sabra Health Care REIT, Inc.
| 1 day | +2.08% | ||
| 1 week | -0.52% | ||
| Current month | -1.69% | ||
| 1 month | +2.84% | ||
| 3 months | +0.68% | ||
| 6 months | +5.33% | ||
| Current year | +10.74% |
| 1 week | 18.72 |  | 19.44 |
| 1 month | 18.3 | | 19.6 |
| Current year | 15.6 | | 19.97 |
| 1 year | 15.6 | | 19.97 |
| 3 years | 10.08 | | 20.03 |
| 5 years | 10.08 | | 20.03 |
| 10 years | 5.54 | | 29.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rick Matros
CEO | Chief Executive Officer | 71 | 2010-05-09 |
Michael Costa
DFI | Director of Finance/CFO | 46 | 2021-12-31 |
Peter Nyland
PRN | Corporate Officer/Principal | - | 2012-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Rick Matros
CHM | Chairman | 71 | 2010-11-24 |
Craig Barbarosh
BRD | Director/Board Member | 57 | 2010-11-02 |
Michael Foster
BRD | Director/Board Member | 71 | 2010-11-02 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 13.8% | 303 M€ | -21.05% | - |
| 0.23% | 165 M€ | +0.34% | - |
| 0.15% | 0 M€ | -.--% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.08% | -0.52% | +9.60% | +49.84% | 4.78B | |
| +0.95% | -8.60% | +44.62% | +177.25% | 128B | |
| +0.76% | -3.41% | +29.96% | +67.55% | 36.57B | |
| +0.55% | -3.85% | +12.14% | +49.35% | 12.99B | |
| -0.36% | -2.35% | -19.94% | -34.80% | 11.55B | |
| +1.18% | -5.71% | +65.96% | - | 8.42B | |
| +1.00% | -3.74% | +25.96% | +85.25% | 8.1B | |
| -1.04% | -1.26% | -0.23% | -11.63% | 6.04B | |
| +1.61% | +1.61% | +30.54% | +149.32% | 4.46B | |
| +1.87% | -1.43% | +6.23% | +38.76% | 3.68B | |
| Average | +0.86% | -2.74% | +20.48% | +63.43% | 22.48B | |
| Weighted average by Cap. | +0.84% | -6.14% | +34.31% | +125.23% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 756M 644M 601M 566M 1.04B 68.45B 1.14B 7.02B 2.72B 32.26B 2.84B 2.78B 118B | 850M 724M 677M 637M 1.17B 77.01B 1.28B 7.9B 3.06B 36.3B 3.19B 3.12B 132B |
| Net income | 168M 143M 134M 126M 232M 15.21B 253M 1.56B 605M 7.17B 630M 617M 26.17B | 191M 163M 152M 143M 263M 17.28B 287M 1.77B 687M 8.14B 716M 701M 29.72B |
| Net Debt | 2.57B 2.19B 2.04B 1.92B 3.54B 232B 3.86B 23.83B 9.24B 110B 9.63B 9.42B 400B | 2.64B 2.25B 2.1B 1.98B 3.64B 239B 3.98B 24.53B 9.52B 113B 9.91B 9.7B 411B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 19.18 $ | +2.08% | 2,479,696 |
| 25-12-11 | 18.79 $ | -1.11% | 2,838,348 |
| 25-12-10 | 19.00 $ | -1.61% | 4,777,117 |
| 25-12-09 | 19.31 $ | +0.36% | 2,548,633 |
| 25-12-08 | 19.24 $ | -0.21% | 4,083,255 |
Delayed Quote Nasdaq, December 12, 2025 at 04:00 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SBRA Stock
Select your edition
All financial news and data tailored to specific country editions
